Install
- 190articles · 30d
- 16+ hour agolatest article
- Aug 17, 2026earliest in window
- 89%with images
- 244avg words
- Medical 137
- Health & Wellness 101
- Economy, Business & Finance 83
- Health 74
- Business & Industrial 68
- Finance & Business 35
- Science & Technology 21
- News 14
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Kaisha Pharma establishes Italy hub to drive global business development
4+ day, 15+ hour ago (367+ words) Kaisha Pharma has established Kaisha Pharma International in Italy as its global business development and customer support hub. The move marks latest step in the company’s strategy to build an international pharmaceutical packaging business. Based in Italy, Kaisha Pharma International…...
AstraZeneca breast cancer drug wins US approval after trial cuts progression risk by 56%
1+ week, 9+ hour ago (64+ words) The US Food and Drug Administration’s accelerated approval is based on results from the Phase III SERENA-6 trial Indian Immunologicals seeks probe into NSQ Abhayrab vials, says samples differ from genuine batch Dr. Jitendra Singh calls for early industry partnership…...
Fosun Pharma announces HK$1 billion H-share buyback
1+ week, 16+ hour ago (289+ words) Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma) has announced an H-share repurchase plan of up to HK$1 billion, with the repurchased shares to be either cancelled or held as treasury shares. The company said the programme has come into…...
Summit’s ivonescimab delivers overall survival win against pembrolizumab in Phase III lung cancer trial
1+ week, 1+ day ago (68+ words) Indian Pharma Post Summit’s ivonescimab delivers overall survival win against pembrolizumab in Phase III lung cancer trial Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants Implementing a digital transformation in chemical operations to maximize profitability The…...
Systech launches TraceIQ for intelligent pharma traceability
1+ week, 2+ day ago (305+ words) The first generation of enterprise traceability platforms was developed primarily to meet serialization mandates, exchange data with trading partners, and satisfy regulatory reporting requirements. Those systems established the compliance foundation the industry relies on today. But as regulations evolve and…...
Lupin gets US FDA nod for Modafinil tablets
1+ week, 2+ day ago (155+ words) Global pharmaceutical major Lupin Limited has received approval from the U.S. Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Modafinil Tablets USP, 100 mg and 200 mg. The approved tablets are bioequivalent to Provigil, the reference listed drug…...
AstraZeneca completes Dizal deal for lung cancer drug Zegfrovy
1+ week, 5+ day ago (60+ words) The deal gives AstraZeneca global control of a drug targeting a particularly aggressive form of lung cancer with significant unmet treatment needs Medtronic to invest $700 million in Hong Kong surgical robotics firm Scan.com raises $220 million to expand US medical…...
Novartis’ Remibrutinib delivers positive Phase III results in relapsing multiple sclerosis
1+ week, 5+ day ago (47+ words) The results point to potential benefits beyond relapse control Medtronic to invest $700 million in Hong Kong surgical robotics firm Scan.com raises $220 million to expand US medical imaging network India Glycols demerges biopharma business into separate entity Dr. Vineet Talwar…...
Lilly’s Taltz-Zepbound combination delivers stronger one-year results in psoriatic disease & obesity trials
1+ week, 6+ day ago (85+ words) indianpharmapost.com Lilly’s Taltz-Zepbound combination delivers stronger one-year results in psoriatic disease & obesity trials The results build on statistically superior outcomes reported at Week 36, when the combination outperformed Taltz alone on key disease and metabolic measures Chasing Consistency: Centralizing operations…...
Genentech to invest $750 million in new injectable manufacturing facility in Oregon
2+ week, 8+ hour ago (298+ words) Roche unit plans end-to-end fill-finish site in Hillsboro to support portfolio and pipeline injectables The planned facility will be built on the same campus as Genentech’s existing Hillsboro manufacturing site and will provide end-to-end fill-finish manufacturing for a range of…...